Join
Live feed
·
PRReleasevia Quantisnow
Iovance Biotherapeutics Inc. logo

Iovance Biotherapeutics Announces Regulatory and Clinical Updates for Lifileucel in Melanoma

ByQuantisnow·Wall Street's wire, on your screen.
IOVA· Iovance Biotherapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IOVA (Iovance Biotherapeutics Inc.) and more on Quantisnow.